Literature DB >> 28724524

Assignment of Weight-Based Antibody Units for Four Additional Serotypes to a Human Antipneumococcal Standard Reference Serum, 007sp.

D Goldblatt1, A McKeen2, P Burbidge3, S McElhiney2, L McLaughlin2, A Johnson2, M Rauh4, P C Giardina2.   

Abstract

The pneumococcal enzyme-linked immunosorbent assay (ELISA) reference standard serum, lot 89SF, had been in use since 1990 and was replaced with a new reference standard serum, 007sp, in 2013. This serum was generated under an FDA-approved clinical protocol where 278 adult volunteers were immunized with the 23-valent unconjugated polysaccharide vaccine Pneumovax II and a unit of blood was obtained twice within 120 days following immunization. Pooled serum was prepared from the plasma, filled at 6 ml per vial, and lyophilized. Five independent laboratories participated in bridging the serotype-specific IgG assignments of 89SF to 007sp to establish equivalent reference values for 13 pneumococcal capsular serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F) using the WHO reference ELISA. A subsequent follow-up study established equivalent reference values for an additional seven serotypes (8, 10A, 11A, 12F, 15B, 22F, 33F). In this study, three laboratories assigned weight-based IgG concentrations in micrograms per milliliter of serum to 007sp for four additional serotypes: 2, 9N, 17F, and 20A. This study completes the assignment of serotypes for 89SF to 007sp. In addition, the IgG antibody assignments for a 12-member WHO quality control (QC) serum panel were extended to cover the four additional serotypes. Agreement was excellent, with a concordance correlation coefficient (rc ) of >0.996 when values from each laboratory were compared to the assigned values for the 12 WHO QC sera. The 007sp preparation has replaced 89SF as the pneumococcal reference standard. Sufficient quantities of 007sp are projected to be available for the next 25 years.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  conjugate; pneumococcus; vaccines

Year:  2017        PMID: 28724524      PMCID: PMC5585694          DOI: 10.1128/CVI.00194-17

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  10 in total

1.  An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay study.

Authors:  B D Plikaytis; D Goldblatt; C E Frasch; C Blondeau; M J Bybel; G S Giebink; I Jonsdottir; H Käyhty; H B Konradsen; D V Madore; M H Nahm; C A Schulman; P F Holder; T Lezhava; C M Elie; G M Carlone
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

Review 2.  Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides.

Authors:  Catherine M Wernette; Carl E Frasch; Dace Madore; George Carlone; David Goldblatt; Brian Plikaytis; William Benjamin; Sally A Quataert; Steve Hildreth; Daniel J Sikkema; Helena Käyhty; Ingileif Jonsdottir; Moon H Nahm
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

3.  Assignment of Weight-Based Antibody Units for Seven Additional Serotypes to a Human Pneumococcal Standard Reference Serum, 007sp.

Authors:  D Goldblatt; C Y Tan; P Burbidge; S McElhiney; L McLaughlin; R Tucker; M Rauh; M Sidhu; P C Giardina
Journal:  Clin Vaccine Immunol       Date:  2015-09-09

4.  Assignment of weight-based antibody units for 13 serotypes to a human antipneumococcal standard reference serum, lot 89-S(f).

Authors:  Sally A Quataert; Kate Rittenhouse-Olson; Carol S Kirch; Branda Hu; Shelley Secor; Nancy Strong; Dace V Madore
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

5.  Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay.

Authors:  N F Concepcion; C E Frasch
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

6.  Biochemical, genetic, and serological characterization of two capsule subtypes among Streptococcus pneumoniae Serotype 20 strains: discovery of a new pneumococcal serotype.

Authors:  Juan J Calix; Richard J Porambo; Allison M Brady; Thomas R Larson; Janet Yother; Chitrananda Abeygunwardana; Moon H Nahm
Journal:  J Biol Chem       Date:  2012-06-26       Impact factor: 5.157

7.  A concordance correlation coefficient to evaluate reproducibility.

Authors:  L I Lin
Journal:  Biometrics       Date:  1989-03       Impact factor: 2.571

8.  Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S.

Authors:  S A Quataert; C S Kirch; L J Wiedl; D C Phipps; S Strohmeyer; C O Cimino; J Skuse; D V Madore
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

9.  Establishment of a new human pneumococcal standard reference serum, 007sp.

Authors:  D Goldblatt; B D Plikaytis; M Akkoyunlu; J Antonello; L Ashton; M Blake; R Burton; R Care; N Durant; I Feavers; P Fernsten; F Fievet; P Giardina; K Jansen; L Katz; L Kierstead; L Lee; J Lin; J Maisonneuve; M H Nahm; J Raab; S Romero-Steiner; C Rose; D Schmidt; J Stapleton; G M Carlone
Journal:  Clin Vaccine Immunol       Date:  2011-08-18

10.  The pneumococcal common antigen C-polysaccharide occurs in different forms. Mono-substituted or di-substituted with phosphocholine.

Authors:  C Karlsson; P E Jansson; U B Skov Sørensen
Journal:  Eur J Biochem       Date:  1999-11
  10 in total
  2 in total

1.  Creation, characterization, and assignment of opsonic values for a new pneumococcal OPA calibration serum panel (Ewha QC sera panel A) for 13 serotypes.

Authors:  Robert L Burton; Han Wool Kim; Soyoung Lee; Hun Kim; Jee-Hyun Seok; Sang Heon Lee; Anne Balloch; Paul Licciardi; Rachel Marimla; Sejong Bae; Moon H Nahm; Kyung-Hyo Kim
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

2.  Intracellular survival of Streptococcus pneumoniae in human alveolar macrophages is augmented with HIV infection.

Authors:  Tinashe K Nyazika; Lusako Sibale; Joseph Phiri; Megan De Ste Croix; Zydrune Jasiunaite; Christopher Mkandawire; Rose Malamba; Anstead Kankwatira; Miriam Manduwa; Daniela M Ferreira; Tonney S Nyirenda; Marco R Oggioni; Henry C Mwandumba; Kondwani C Jambo
Journal:  Front Immunol       Date:  2022-09-20       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.